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Abstract Previous studies have demonstrated that addition of
glutathione at the penultimate Cys374 residue of actin results in
filaments with diminished mechanical stability. In the present
work substitutions introducing a negatively charged (Asp and
Glu) or a neutral (Ala) amino acid at position 374 of the human
L-actin and tagged at the N-terminus with the flag epitope were
studied by transient transfections into Ishikawa human endo-
metrial and opossum kidney cells. Immunofluorescence revealed
that microfilaments which incorporated negatively charged
mutants were partially to severely disorganized when compared
to the almost well-formed actin-Ala374 filaments or the wild type
actin filaments. Furthermore, microfilaments containing either
negatively charged mutant were more sensitive to the destabiliz-
ing action of cytochalasin B. In addition, Triton fractionation
revealed a considerable reduction of flag-actin content in the
Triton insoluble fraction for cells expressing Asp374 or Glu374
mutant compared to wild type actin. These results demonstrate
that negatively charged amino acid residues at the exposed C-
terminal tail strongly affect actin microfilament organization and
dynamics in vivo.
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1. Introduction
Actin is a highly conserved ubiquitous cytoskeletal protein,
essential for multiple cellular functions including cytokinesis,
cell morphology, cell motility, and cell growth [1]. In non-
muscle cells rapid changes of the assembly and organization
of the micro¢laments seem to be regulated by various extra-
cellular stimuli, indicating participation of actin dynamics in
receiving and mediating signals [2^8]. Actin’s key role in these
processes has been greatly advanced by the elucidation of the
atomic structure of monomeric G-actin in complex with dif-
ferent actin binding proteins [9^11], as well as by the construc-
tion of an atomic model predicting the orientation and the
interactions between subunits within the F-actin ¢lament [12^
15]. In all known actin sequences the three C-terminal residues
(Lys373Cys374Phe375) are conserved pointing to a possible
functional importance of this segment. However, the exact
location of this segment in both the monomeric and polymer
structure is still uncertain. In the case of G-actin the C-termi-
nal segment is believed to be exposed on the surface of the
molecule, accessible to solvent and highly mobile. Upon
polymerization it adopts a di¡erent conformation which
leaves Cys374 exposed on the surface of the ¢lament [13,16]
while Phe375 has been proposed to participate in one of the
actin monomer-monomer contact interfaces [12].
The detailed role of the C-terminal tail in actin polymer-
ization dynamics in vitro has been studied previously using
actin modi¢ed at the penultimate Cys374 residue with thiol
compounds [17^20], C-terminally truncated actin [20^22],
and mutant human L-actin in which Cys374 was substituted
by serine [23]. In all cases, the properties of ¢laments as-
sembled from modi¢ed actin were changed, including reduced
stability, enhanced ATPase activity and increased critical con-
centration. The in vivo importance of the C-terminal segment
for actin assembly has been studied in the yeast Saccharomy-
ces cerevisiae by successive deletion of the three last amino
acid residues [24]. Deletion of all three residues was lethal,
while cells expressing deletions of Phe375 or Cys374Phe375
were temperature sensitive, with loss of ¢lamentous actin
structures and randomly distributed actin patches at the
non-permissive temperature. In contrast, yeast cells expressing
actin point mutants (Cys374CAla or Lys373CMet) exhibited
no phenotypic alterations. Combined together these structur-
al, biochemical and genetic data stress the importance of the
C-terminal segment in polymerization dynamics and ¢lament
stabilization.
In order to investigate more precisely the importance of the
C-terminal tail in actin micro¢lament polymerization and sta-
bilization in vivo, we focused on the role of Cys374. For this
purpose three di¡erent mutations, introducing either a nega-
tive (Asp or Glu) or a neutral (Ala) side chain charge in place
of the sulfhydryl side chain of cysteine, were prepared. The
negatively charged substitutions were designed such that they
would chemically mimic the previously characterized gluta-
thionyl-actin [18,19,25]. These actin mutants were expressed
in two di¡erent mammalian cell lines, Ishikawa human endo-
metrial adenocarcinoma cells and opossum kidney cells. Here
we report studies on the e¡ect of the exogenous mutant actins
on the organization and overall integrity of the actin cytoske-
leton and on the state of polymerization of the mutant actins.
2. Materials and methods
2.1. Materials
Restriction enzymes and DNA polymerases were obtained from
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New England Biolabs (Beverly, MA, USA) or Gibco-BRL (Life Tech-
nologies, Inc., Inchinnan, UK). All oligonucleotides were from the
Microchemical Facility of the IMBB (Heraklion, Greece). The TNT
T7 Quick coupled transcription/translation system was from Promega
(Madison, WI, USA). The ECL Western blotting kit, anti-actin anti-
body, Hyper¢lm-ECL ¢lms, Sequenase v2 kit and 35S-labeled methio-
nine were from Amersham Corp. (Arlington Heights, IL, USA). The
anti-£ag M2 monoclonal antibody was from IBI/Kodak (New Haven,
CT, USA) and the anti-mouse IgG antibody conjugated to £uorescein
isothiocyanate (FITC) from Chemicon (Temecula, CA, USA). Rhod-
amine-phalloidin and slow fade reagent were from Molecular Probes
Inc. (Eugene, OR, USA). All other chemicals were obtained from
usual commercial sources at the purest grade available.
2.2. Construction of mutant actin cDNAs
All DNA manipulations were performed according to standard
procedures [26]. Actin point mutations were introduced by PCR.
The human L-actin cDNA sequence, bp 34^1184 (including the whole
protein encoding sequence (bp 42^1167)), cloned into the EcoRV site
of pBluescript SK (pBS-hL-actin, a generous gift from Dr. G. Mav-
rothalassitis) served as template. For the generation of point mutants
Cys374CAla374, Asp374 or Glu374 appropriate 3P primers (5P GGC
TCG AGG ATC CGC CTA GAA GGC TTT GCG GTG GAC 3P,
5P GGC TCG AGG ATC CGC CTA GAA GTC TTT GCG GTG
GAC 3P, 5P GGC TCG AGG ATC CGC CTA GAA TTC TTT GCG
GTG GAC 3P, where bold letters indicate the mutated codons) and a
common 5P primer (5P GGC TCG AGA AGC TTC ACC ATG GAT
GAT GAT ATC GCC GC 3P) were designed and used. In the case of
Cys374CAsp374 or Glu374 mutants, the PCR product was digested
with HindIII and BamHI and cloned into the mammalian expression
vector pCB6. The two pCB6 constructs were digested with EcoRV
and BamHI and the insert (actin sequence, bp 54^1174, lacking the
¢rst three amino acid residues) was transferred to EcoRV/BamHI
digested pSG5-£ag vector (a generous gift from Dr. E. Hatzivassiliou,
Harvard Medical School, USA), downstream of the £ag epitope se-
quence and in the same frame with it. The resulting constructs pSG5-
£ag-actin-Asp374 and pSG5-£ag-actin-Glu374 express an N-terminal
£ag-tagged actin mutant, where the eight residue £ag epitope sequence
is linked, through a six amino acid long linker to actin amino acids 4^
375, mutated at position 374. To generate pSG5-£ag-actin-Ala374 the
PCR product was digested with EcoRV and BamHI and the resulting
fragment was inserted to EcoRV/BamHI digested pSG5-£ag vector.
Finally, for construction of the pSG5-£ag-actin-Cys374 (wt) control
plasmid, the EcoRV/XhoI actin insert from pBS-hL-actin was sub-
cloned into pSG5-£ag vector. All mutations introduced by PCR and
the in-frame fusion of the £ag epitope with the actin N-terminus were
veri¢ed by DNA sequencing.
2.3. Cell culture and transient transfections
Ishikawa cells were established as a permanent cell line from a well-
di¡erentiated endometrial adenocarcinoma [27]. Opossum kidney cells
(OK cells) provided by the American Type Culture Collection were
studied between passages 40 and 50. Both cell lines were maintained
as monolayers in regular growth medium as previously described
[4,27]. For immuno£uorescence and Western analysis experiments,
Ishikawa or OK cells plated at 2^2.5U105 per 35 mm diameter dish
were transiently transfected with 6 Wg of pSG5-£ag-actin-X374 con-
struct (where X = Cys(wt), Ala, Asp or Glu) by the calcium-phosphate
protocol [28]. After overnight incubation with the DNA-calcium
phosphate co-precipitate, cells were washed and cultured in regular
growth medium for 24 h. For immuno£uorescence experiments cells
were then trypsinized and plated in new 35 mm dishes with glass
coverslips and were incubated overnight in regular growth medium.
2.4. Fluorescence microscopy
For morphological observations by £uorescence microscopy, tran-
siently transfected Ishikawa or OK cells were cultured for 24 h on
glass coverslips in regular growth medium, followed by 12 h incuba-
tion in medium lacking serum. In the appropriate experiments Ishi-
kawa cells were incubated for 1 h with increasing concentrations of
cytochalasin B (0.5^7.5 WM) or with 1 WM phallacidin. Control cells
were treated with the same amount of ethanol. Cells were ¢xed with
3.7% v/v formaldehyde in phosphate bu¡er saline (PBS) and subse-
quently permeabilized with acetone. Specimens were incubated with
anti-£ag M2 monoclonal antibody (1:100 dilution in PBS containing
1.5% FCS) at 4‡C for 1 h (indirect £uorescence), followed by incuba-
tion with secondary goat anti-mouse IgG antibody conjugated to
£uorescein isothiocyanate (FITC) at 4‡C for 1 h. Finally specimen
were mounted on glass slides with slow-fade. For double £uorescent
experiments, rhodamine-phalloidin staining followed the indirect im-
muno£uorescence step. Cells were incubated with 0.25 WM rhod-
amine-phalloidin in a humid chamber for 40 min at room temperature
(direct £uorescence). The coverslips were observed using either a con-
focal laser scanning module as previously described [5] or an Olympus
BH-2 microscope equipped with epi£uorescent illumination and pho-
tographed with a 35 mm Olympus (C-35AD-4) camera on Kodak
P3200 black and white ¢lm.
2.5. Western analysis
2.5.1. Total £ag-actin determination. For detection of £ag-actin,
Ishikawa cells were cultured for 24 h following transfection in regular
growth medium. Cells were washed with ice-cold PBS and immedi-
ately scraped into 100 Wl of lysis bu¡er (0.9% NaCl, 20 mM Tris-HCl,
0.5% Triton X-100, 400 WM PMSF, 10 WM leupeptin, pH 7.4). Equal
amounts of total protein (50 Wg) of the cell extracts were subjected to
SDS-PAGE and the resolved proteins were transferred to nitrocellu-
lose membranes, using an LKB electroblot apparatus (LKB, Bromma,
Sweden). Nitrocellulose blots were incubated with monoclonal mouse
anti-£ag M2 and anti-actin antibodies, followed by incubation with
the appropriately labelled secondary antibody, by using the ECL
Western blotting kit.
2.5.2. Flag-actin determination in detergent extracts. For measure-
ments of monomeric (Triton soluble) and polymeric (Triton insoluble)
actin levels, Ishikawa and OK cells were cultured for 24 h following
transfection in regular growth medium, followed by 12 h incubation in
medium lacking serum. In the appropriate experiments, Ishikawa cells
were incubated for 30 min with 1037 M dexamethasone. Control cells
were incubated with the same amount of vehicle. After treatment,
Triton X-100 fractionation was performed as previously described
[29]. Equal volumes of each fraction were subjected to SDS-PAGE
and Western analysis as above. Band intensities were quanti¢ed by the
Molecular Analyst Software (Bio-Rad, Palo Alto, CA, USA).
2.6. Co-assembly of wild type and mutant £ag-actins with carrier actin
Wild type or mutant £ag-actins were transcribed/translated from
the pSG5-£ag-actin-X374 constructs in the presence of 35S-labeled me-
thionine, using the TNT T7 Quick coupled transcription/translation
system according to the manufacturer’s instructions. The ¢nal volume
of each transcription/translation reaction was 25 Wl. Rabbit skeletal
muscle actin was isolated from acetone powder and used for the co-
assembly assays to a ¢nal concentration of 22 WM in G-bu¡er (Tris
HCl 2 mM, ATP 0.2 mM, pH 7.4). 20 Wl of the transcription/trans-
lation reaction mixture was added to G-actin and polymerization was
started by addition of MgCl2 to a ¢nal concentration of 2 mM. After
1 h incubation at room temperature, assembled actin was pelleted by
centrifugation at 150 000Ug in a Beckman TLS 55 rotor (Beckman
Instruments, Palo Alto, CA, USA) at 4‡C for 15 min. Pellets were
resuspended in Tris-SDS bu¡er (Tris-HCl 0.625 M pH 7.4, 2% SDS
and 10% glycerol) and equivalent supernatant and pellet volumes were
analyzed by SDS-PAGE. After electrophoresis the gel was stained
with Coomassie brilliant blue, destained, vacuum-dried and exposed
to Hyper¢lm-ECL ¢lm for a minimum of 18 h.
3. Results and discussion
3.1. Construction of point substitution mutants of Cys374 in
human L-actin and expression of mutant actins in
mammalian cells
Three mutations in human L-actin were generated by sub-
stitution of Cys374 with Ala374, Asp374 or Glu374. Wild type
(wt) and mutant actins were tagged with the £ag epitope. The
resulting pSG5-£ag-actin constructs, when transfected to
mammalian cells, should express actin with the £ag epitope
tagged at the N-terminus through a six amino acid long linker
(Fig. 1A) and thus be easily distinguished from endogenous
cellular L-actin. Indeed, immunoblot analysis of total cell ex-
tracts from Ishikawa cells transiently expressing all four con-
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structs (wt and the three mutants) showed that the anti-£ag
antibody detected a protein of the appropriate molecular size
(Fig. 1Ba, lanes 2,3,5,7). Furthermore, the electrophoretic mo-
bility of this band was identical to that of cellular or puri¢ed
rabbit skeletal muscle actin recognized by a monoclonal anti-
actin antibody (Fig. 1Bb, lanes 1^8). The speci¢city of the
anti-£ag antibody was evident from the fact that in non-trans-
fected Ishikawa cells or in cells transfected with the non-£ag-
actin constructs no signal was observed (Fig. 1Ba, lanes 1,4,6).
3.2. E¡ect of £ag-actin expression on the actin cytoskeleton
architecture ^ Mutant actin protein incorporation in
micro¢laments in vivo
Ishikawa cells transfected with £ag-actins were indirectly
stained with the anti-£ag antibody and analyzed with confocal
laser scanning microscopy. For £ag-actin-Cys374 (wt) well or-
ganized micro¢lament structures, including stress ¢bers, were
observed (Fig. 2A) and the overall cell morphology was very
similar to the actin cytoskeleton of non-transfected cells when
stained directly with rhodamine-phalloidin. Thus, introduc-
tion of exogenous actin into mammalian cells did not cause
any major disturbance in the organization of the actin cyto-
skeleton, although downregulation of L and/or Q actin expres-
sion cannot be excluded [30,31]. In addition, the presence of
the N-terminally tagged £ag epitope which resulted in se-
quence alterations of this segment of the molecule (Fig. 1A
and Section 2) did not result in aberrant behavior of the actin
molecule at least at the level of incorporation into functional
micro¢laments and cytoskeletal organization. The mutations
at position 374 exhibited various e¡ects on the actin cytoske-
leton organization. The Ala374 mutant performed essentially
like the wt actin as judged by immuno£uorescence studies
(Fig. 2B). In contrast, the e¡ect of £ag-actin-Asp374 or £ag-
actin-Glu374 expression was very severe, ranging from partial
disruption to complete disorganization of micro¢lament struc-
tures. In most specimens di¡use staining with simultaneous
intense peripheral submembranous £uorescence, probably
due to cortical £ag-actin, was observed (Fig. 2C,D). In
some cases shorter ¢lamentous structures and even shorter
stress ¢bers were seen (Fig. 2, C4 and D4). A positive corre-
lation between the intensity of £uorescence of each transfected
cell with the level of cytoskeletal disorganization was observed
indicating that the diversity of the e¡ect may be due to di¡er-
ences in the expression levels of the mutant actins obtained at
individual cells.
When £ag-actin constructs were transfected to OK cells,
expression of £ag-wt or £ag-Ala374 mutant had no e¡ect on
micro¢lament organization, in agreement with the results ob-
tained for Ishikawa cells. The actin cytoskeleton architecture
was well preserved as was revealed by indirect anti-£ag stain-
ing, as well as by double staining. A well organized array of
stress ¢bers and a bright staining of leading lamellae and
membrane ru¥es were observed by indirect immuno£uores-
cence (Fig. 3a,b). In contrast, expression of negatively charged
Asp374 and Glu374 mutants did not produce the extensive del-
eterious e¡ect obtained in Ishikawa cells. In the majority of
specimens stress ¢bers were still observed, albeit in many cases
less extended as compared to £ag-wt expressing cells. Further-
Fig. 1. A: Schematic representation of (a) L-actin and (b) wt and
mutant £ag-actin amino acid sequences. The L-actin sequence is rep-
resented as white box and the number of amino acid (aa) residues
in each protein is indicated. Amino- and carboxy-terminal aa se-
quences are shown with residue 374 in bold. In (b) the £ag epitope
is represented as a diagonally hatched box (bold aa sequence) and
the linker segment as a vertically hatched box. The nomenclature of
the four £ag-actins used in this study is listed along their corre-
sponding carboxy-terminal aa sequence. B: Expression of £ag-actin
constructs in Ishikawa cells. Immunoblot analysis of equal amounts
of total cellular protein from Ishikawa cells transfected with di¡er-
ent actin constructs using monoclonal antibodies against (a) the £ag
epitope and (b) actin. Lane 1: non-transfected Ishikawa cells; lanes
2^7: Ishikawa cells transfected with pSG5-£ag-actin-Cys374 (wt)
(lane 2), pSG5-£ag-actin-Asp374 (lane 3), pCB6-actin-Asp374 (lane 4),
pSG5-£ag-actin-Glu374 (lane 5), pCB6-actin-Glu374 (lane 6), pSG5-
£ag-actin-Ala374 (lane 7); lane 8: puri¢ed rabbit skeletal muscle ac-
tin. Arrowheads indicate the protein molecular marker positions.
Table 1
Quanti¢cation of the distribution of £ag-actin into Triton X-100 fractions
Cells transfected with £ag-actin Ishikawa cells OK cells
% TI/TS+TI % wt % TI/TS+TI % wt
Wild type (Cys374) 59.15 þ 4.8 (n = 5) 100 68.0 þ 7.1 (n = 10) 100
Mutant Ala374 48.00 þ 4.6** (n = 7) 81.1 51.2 þ 5.9** (n = 10) 75.3
Mutant Asp374 40.10 þ 2.6** (n = 3) 67.8 28.4 þ 10.4** (n = 11) 41.7
Mutant Glu374 39.10 þ 11.4* (n = 5) 66.1 37.9 þ 11.2** (n = 10) 55.7
Ratio of Triton insoluble (TI) to total (Triton soluble and insoluble, TS+TI) cellular £ag-actin from transiently transfected Ishikawa and OK
cells. Values are mean þ S.D. from n distinct experiments. Signi¢cance levels (de¢ned by unpaired Student’s t-test) : *P6 0.05; **P6 0.01.
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more cells completely lacking ¢lamentous structures were very
rare. The most pronounced e¡ect, besides partial stress ¢ber
disruption, was the increase in the intensity of the leading
lamellae and membrane ru¥e staining. This was often accom-
panied by the appearance of intensely stained submembranous
extensions with di¡erent morphology from lamellipodia, ¢lo-
podia or membrane ru¥es (Fig. 3c,d). The di¡erent behavior
of the two cell lines may be due to the better formed and more
extended stress ¢ber organization in OK cells compared to the
micro¢lament architecture of Ishikawa cells. Additionally, the
observed subcellular localization of the negatively charged
mutants being incorporated primarily into highly motile re-
gions in OK cells, while appearing rather di¡use in Ishikawa
cells, may also contribute to the di¡erence in the intensity of
micro¢lament disorganization observed between these two cell
lines.
The di¡erences observed in the actin cytoskeletal organiza-
tion of cells expressing actin mutants could not be attributed
to the partitioning of the actin mutants into monomeric pools
or loss of their ability to interact with endogenous actin, since
double staining revealed identical £uorescence images for both
indirect anti-£ag/FITC and direct rhodamine-phalloidin stain-
ing (data not shown). The fact that micro¢lament structures
which contain only endogenous cellular actin were not de-
tected suggests that exogenous negatively charged actin mol-
ecules can be recognized by the cell as interchangeable units
capable of actively participating in polymerization dynamics.
Similarly, wt and Ala374 mutant were always incorporated
into micro¢lament structures together with endogenous cellu-
lar actin. No segregation of the transfected £ag-actins from
the cellular actin was obvious. The observed structures must
result from the active incorporation of £ag-actins to the en-
Fig. 2. Confocal laser scanning analysis of Ishikawa cells expressing £ag-actins stained indirectly with anti-£ag antibody. Ishikawa cells express-
ing (A) £ag-actin-Cys374 (wt), (B) £ag-actin-Ala374, (C) £ag-actin-Asp374 and (D) £ag-actin-Glu374. 1^4 represent scanning sections from the
upper cytoplasmic region towards the attachment site of the cells. The step size of the optical sections was adjusted to 0.5 Wm (bar: 10 Wm).
Fig. 3. Fluorescence analysis of OK cells expressing £ag-actins stained indirectly with anti-£ag antibody. OK cells expressing (a) £ag-actin-
Cys374 (wt), (b) £ag-actin-Ala374, (c) £ag-actin-Asp374 and (d) £ag-actin-Glu374.
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dogenous dynamic actin cytoskeleton and not from self-
polymerization.
3.3. Quantitation of £ag-actin subcellular distribution by Triton
X-100 fractionation
The incorporation of £ag-actins into micro¢laments in
Ishikawa and OK cells was analyzed by quantitative immuno-
blot determination of the Triton soluble (TS) and insoluble
(TI) cellular £ag-actin content. As calculated from the relative
band intensities, in both cell lines wt £ag-actin was detected
at a relative distribution of 30^40% soluble and 60^70% in-
soluble (Table 1) which falls well within the range of distri-
bution of the endogenous cellular actin of these two cell lines
[4,6]. In the case of Ishikawa cells the TI/TI+TS ratio for
actin-Ala374 exhibited a statistically signi¢cant decrease of
18.9% compared to that for wt actin. However, the TI/
TI+TS ratio was decreased by 32.2% for actin-Asp374 and
by 33.9% for actin-Glu374 (Table 1). Surprisingly, considering
the di¡erences observed in the immuno£uorescence images,
similar or rather more pronounced results were obtained for
OK cells. The TI/TI+TS ratio decreased by 24.7% for actin-
Ala374 compared to wt actin, by 58.3% for actin-Asp374 and
by 44.3% for actin-Glu374 (Table 1).
3.4. In vitro incorporation of mutant actin protein in
micro¢laments
Flag-actins, wt and the three mutants were transcribed/
translated in the presence of 35S-labeled methionine and their
ability to co-polymerize with puri¢ed rabbit skeletal muscle
actin in vitro was studied. When transcription/translations
were added to carrier actin and allowed to polymerize all
four £ag-actins (wt and the three mutants) were co-sedi-
mented with carrier actin. In each case the majority of the
labeled actin was detected in the pellet (Fig. 4B, lanes
2,4,6,8). Some unpolymerized £ag-actin was also detected in
the supernatant (Fig. 4B, lanes 1,3,5,7). This result does not
indicate a reduced ability of £ag-actin to polymerize, but it
rather suggests that the in vitro transcribed/translated actin
follows the distribution of carrier actin (Fig. 4A). Further-
more, no di¡erence in the amount of pelleted £ag-actin be-
tween wt and mutants was observed indicating that mutants
are capable of polymerization, although changes in polymer-
ization dynamics, such as on and o¡ rates for barbed and
pointed ¢lament ends or critical concentration, cannot be ex-
cluded.
3.5. Morphological and quantitative analysis of the stability
and dynamics of mutant actin cytoskeleton
The e¡ect of cytochalasin B and phallacidin on cells trans-
fected with £ag-actin was studied by indirect immuno£uores-
cence and confocal laser scanning microscopy. At relatively
low cytochalasin B concentrations (0.5^2 WM) the micro¢la-
ment organization in £ag-actin-wt and £ag-actin-Ala374 ex-
pressing cells was not altered. In contrast, in £ag-actin-
Asp374 and -Glu374 expressing cells the short ¢lamentous
structures were completely disrupted and actin accumulated
into intensely £uorescent patches, accompanied sometimes
with changes in cell shape (Fig. 5). In the presence of 1 WM
phallacidin no change in the ¢lamentous £ag-actin (wt or
mutant) organization was evident. The e¡ect of phallacidin
was further studied by performing transfection and subse-
quent culture in the continuous presence of 0.1 WM phallaci-
din. Immuno£uorescence analysis as well as Triton X-100
fractionation pointed to a slightly impaired micro¢lament or-
ganization even for wt actin (data not shown).
Finally the e¡ect of dexamethasone on the dynamics of
exogenous £ag-actin was studied by measuring the TI/
TI+TS ratio after treatment of Ishikawa cells for 30 min
with 1037 M dexamethasone, conditions previously shown
Fig. 4. Co-polymerization of £ag-actin and skeletal muscle actin.
Flag-actins, wt or mutants, were in vitro transcribed/translated in
the presence of 35S-labeled methionine, co-assembled with carrier
rabbit skeletal muscle actin and precipitated by ultracentrifugation.
A: Coomassie brilliant blue stained SDS-polyacrylamide gel of
supernatants (lanes 1,3,5,7) and pellets (lanes 2,4,6,8). B: Autora-
diography of the same gel. Carrier actin co-assembled with wt (lanes
1 and 2) or Ala374 (lanes 3 and 4), Asp374 (lanes 5 and 6) and
Glu374 (lanes 7 and 8) mutants.
Fig. 5. E¡ect of cytochalasin B on the actin micro¢lament organiza-
tion of Ishikawa cells expressing £ag-actins. Confocal laser scanning
micrographs of Ishikawa cells expressing (A) £ag-actin-Cys374 (wt),
(B) £ag-actin-Ala374, (C) £ag-actin-Asp374 and (D) £ag-actin-Glu374
stained indirectly with anti-£ag antibody. Cells were incubated for
1 h with cytochalasin B 0.5 WM or 1 WM or with the corresponding
volume of ethanol (control).
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to induce rapid actin polymerization [6,7]. For all three mu-
tants, the TI/TI+TS ratio exhibited a small increase, albeit not
statistically signi¢cant, comparable to that for wt actin (data
not shown), indicating that di¡erential actin cytoskeleton or-
ganization and stability do not necessarily inhibit functional-
ity and the ability to respond to extracellular signals by mod-
ulating the polymerization state.
4. Conclusion
The e¡ect of the expression of the actin mutants studied
here cannot be solely attributed to the removal of the sulf-
hydryl group of Cys374 since the Ala374 mutant behaved sim-
ilarly to the wt. Rather, the e¡ect must be due to a change in
the chemical environment of the C-terminal segment which is
introduced by the negative charge or the hydrogen bonding
ability of the Asp or Glu side chains. Although Cys374 is not
directly implicated in the actin monomer to monomer con-
tacts in the ¢lament it has been proposed that actin polymer-
ization results in a chemical change of the Cys374 environment
which is important for ¢lament assembly and function [16,32].
In addition, the neighboring Phe375 is proposed to be involved
in actin monomer to monomer contacts [12]. Furthermore, it
is already known that the bottom edge of the actin molecule
and especially subdomain 1, where the C-terminal segment is
located, is the binding site for di¡erent actin binding proteins
[33]. Changes at or near these binding sites are expected to
destroy or attenuate the interactions between actin and actin
binding proteins, leading eventually to disorganization of the
micro¢laments, since it is through their association with actin
that actin binding proteins modulate the actin polymerization
dynamics, thus allowing remodeling of actin cytoskeleton in
response to intracellular or extracellular stimuli [34^37]. It is
tempting to speculate that the e¡ect of the negatively charged
mutants is produced by the combination of ¢lament structural
destabilization and inhibition of actin binding protein func-
tion, leading to reduced actin polymerization and establish-
ment of a steady state displaced towards monomeric actin.
This di¡erence in the steady state would result in altered cy-
toskeleton morphology but not necessarily in loss of the abil-
ity to respond to extracellular stimuli, as our preliminary dex-
amethasone results suggest.
In conclusion, this study provides evidence about the im-
portance that the speci¢c chemical environment around the C-
terminus of the actin molecule can have in the state of polym-
erization and the overall cellular integrity of the actin cyto-
skeleton. This is the ¢rst attempt to approach this problem in
mammalian cells and the results obtained are in agreement
with previously published in vitro studies on the role of
Cys374 in actin polymerization dynamics. Finally, the system
of transfected £ag-actins presented here provides a useful tool
in handling questions of regulation of micro¢lament assembly
by structural determinants of the actin molecule itself or by
environmental factors under in vivo conditions.
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